NOK 39.0
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.69 NOK | 57.05% |
2022 | -1.56 NOK | 3.11% |
2021 | -1.61 NOK | -45.05% |
2020 | -1.11 NOK | 57.14% |
2019 | -2.59 NOK | -100.78% |
2018 | -1.29 NOK | -19.44% |
2017 | -1.08 NOK | -35.0% |
2016 | -0.80 NOK | -175.86% |
2015 | -0.29 NOK | -11.54% |
2014 | -0.26 NOK | -431.21% |
2013 | 0.08 NOK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.31 NOK | 14.81% |
2024 Q3 | 0.22 NOK | -29.03% |
2024 Q1 | 0.27 NOK | 142.86% |
2023 Q4 | -0.63 NOK | -1090.93% |
2023 FY | - NOK | 57.05% |
2023 Q1 | -0.06 NOK | 80.66% |
2023 Q3 | -0.05 NOK | -189.81% |
2023 Q2 | 0.06 NOK | 195.15% |
2022 Q3 | -0.65 NOK | -109.68% |
2022 Q1 | -0.45 NOK | 27.42% |
2022 FY | - NOK | 3.11% |
2022 Q4 | -0.32 NOK | 50.77% |
2022 Q2 | -0.31 NOK | 31.11% |
2021 Q3 | -0.44 NOK | -91.3% |
2021 FY | - NOK | -45.05% |
2021 Q2 | -0.23 NOK | 28.13% |
2021 Q1 | -0.32 NOK | -39.13% |
2021 Q4 | -0.62 NOK | -40.91% |
2020 Q2 | -0.09 NOK | 74.47% |
2020 Q1 | -0.36 NOK | 21.74% |
2020 FY | - NOK | 57.14% |
2020 Q4 | -0.23 NOK | 48.89% |
2020 Q3 | -0.45 NOK | -389.66% |
2019 FY | - NOK | -100.78% |
2019 Q4 | -0.46 NOK | -35.29% |
2019 Q3 | -0.34 NOK | 74.24% |
2019 Q1 | -0.47 NOK | 44.71% |
2019 Q2 | -1.32 NOK | -180.85% |
2018 Q4 | -0.85 NOK | -2113.54% |
2018 FY | - NOK | -19.44% |
2018 Q1 | -0.28 NOK | 26.32% |
2018 Q2 | -0.15 NOK | 46.43% |
2018 Q3 | -0.04 NOK | 74.4% |
2017 Q4 | -0.38 NOK | -5.56% |
2017 Q2 | 0.03 NOK | 107.74% |
2017 Q1 | -0.38 NOK | -52.0% |
2017 FY | - NOK | -35.0% |
2017 Q3 | -0.36 NOK | -1324.49% |
2016 Q4 | -0.25 NOK | 41.86% |
2016 Q2 | -0.03 NOK | 57.84% |
2016 Q1 | -0.08 NOK | 36.75% |
2016 FY | - NOK | -175.86% |
2016 Q3 | -0.43 NOK | -1243.75% |
2015 FY | - NOK | -11.54% |
2015 Q3 | -0.14 NOK | 0.0% |
2015 Q4 | -0.12 NOK | 14.29% |
2014 FY | - NOK | -431.21% |
2013 FY | - NOK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Lifecare AS | -0.29 NOK | -137.931% |
Medistim ASA | 5.68 NOK | 112.148% |